![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](pk2156contents.gif)
Acta Cryst. (2009). E65, m379 [ doi:10.1107/S1600536809007703 ]
Abstract: The asymmetric unit of the title compound, [PtCl3.66I0.34(C12H8N2)]·0.5(Cl0.13I1.87), contains a neutral PtIV complex and one half of a halogen molecule. The PtIV ion is six-coordinated in a distorted octahedral environment by two N atoms of the 1,10-phenanthroline ligand and Cl or I atoms. The refinement of the structure and the EDX analysis indicate that the compound is a solid solution in which there is some substitution of Cl for I and vice versa. The chemical formula of the pure state of the compound would have been [PtCl4(C12H8N2)]·0.5I2. In the analysed crystal, two Cl atoms are partially (ca 25% and 9%) replaced by I atoms, and the I2 molecule has a minor component modelled as ICl. As a result of the disorder, the different trans effects of the N and Cl/I atoms are not distinct. The complex displays intermolecular
-
interactions between the six-membered rings, with a centroid-centroid distance of 3.771 (4) Å. There are also weak intramolecular C-H
Cl hydrogen bonds.
Online 11 March 2009
Copyright © International Union of Crystallography
IUCr Webmaster